Features | Partner Sites | Information | LinkXpress
Sign In
Ampronix
Samsung
Schiller

Cancer Therapy Efficacy May Be Determined Using MRI and Oxygen

By Medimaging International staff writers
Posted on 30 Jun 2009
Utilizing a simple magnetic resonance imaging (MRI) scan involving breathing oxygen might help oncologists determine the best treatment for some cancer patients, reported researchers.

Earlier studies have shown that the amount of oxygen present in a tumor can be a predictor of how well a patient will respond to treatment. Tumors with little oxygen tend to grow stronger and resist both radiotherapy and chemotherapy. Until now, however, the only way to measure the oxygen level in a tumor, and thus determine which treatment might be more effective, was to insert a huge needle directly into the cancerous tumor.

The new technique, known as blood oxygen level-dependent (BOLD) MRI, can detect oxygen levels in tumors without the need for an invasive procedure. The patient need only be able to breathe in oxygen when undergoing an MRI. "The patient simply inhales pure oxygen, which then circulates through the bloodstream, including to the tumors,” said Dr. Ralph Mason, professor of radiology at the University of Texas (UT) Southwestern Medical Center (Dallas, USA), director of the UT Southwestern Cancer Imaging Center, and senior author of a study appearing online in June 2009 in an issue of the journal Magnetic Resonance in Medicine (MRM). "Using MRI, we can then go in and estimate how much oxygen a particular tumor is taking up, providing us some insight into how the tumor is behaving and what sort of treatment might be effective.”

The most significant finding, according to Dr. Mason, is that BOLD MRI performed as well as the standard yet more invasive procedure for viewing tumors. That method, known as fluorocarbon relaxometry using echo planar imaging for dynamic oxygen mapping (FREDOM) MRI, requires the injection of a chemical called a reporter molecule directly into the tumor. "The BOLD technique appears to indicate accurately the oxygen levels in tumors,” Dr. Mason said. "Because BOLD is immediately applicable to patients, this holds promise as a new method for predicting response to therapy.”

BOLD MRI has been used extensively in studying brain function, but the procedure has only recently begun to be used to assess blood oxygenation and vascular function in tumors. Physicians at UT Southwestern are already evaluating BOLD MRI in patients with cervical, prostate, and head and neck cancer. They have proposed using it in lung cancer patients as well, reported Dr. Mason. Earlier research has shown that those specific tumor types are more likely to have little oxygen.

In the published study, researchers captured multiple images of breast tumors implanted just below the skin of rats, which were given anesthesia to help them remain still during the imaging process. Humans do not require anesthesia, according to Dr. Mason.

Dr. Mason reported that the team took the research back to the preclinical stage because they needed to better define what physicians were seeing in the clinic and whether the findings were reproducible. He reported that examining each form of cancer in this way presents its own technical challenges. For example, the motion of the lungs or the design of a facemask for breathing oxygen must be taken into account. "If we can prove that the test is meaningful in animals, then it is that much more worthwhile to argue for doing it in a patient. This preclinical work provides the foundation for future clinical studies,” Dr. Mason said. "It helps justify doing a larger clinical trial with the goal of ultimately becoming a diagnostic test for oncologists.”

Researchers currently are trying to determine how much oxygen must be inhaled by a patient in order to be effective. The next step is to expand studies in patients and validate the relevance to more tumor types.

Related Links:
University of Texas Southwestern Medical Center


Supersonic Imagine
ARAB HEALTH
PHS Technologies

Channels

Radiography

view channel
Image: Coronary CT angiography images demonstrate examples of high-risk plaque features. A, Image was obtained in a 63-year-old man with partially calcified plaque, positive remodeling (vertical arrow), and spotty calcium (horizontal arrow). B, A cross-sectional view of a noncalcified plaque in a 65-year-old man demonstrates a napkin-ring sign with a central low-attenuation area, surrounded by a peripheral rim of higher attenuation (arrow) next to the lumen (∗). C, Image in a 60-year-old woman with partially calcified plaque demonstrates a low CT number in the midportion (arrow) (Photo courtesy of the journal Radiology).

Coronary CT Angiography Reveals Link between Coronary Artery Plaque and Liver Disease

Researchers using coronary computed tomography angiography (CCTA) imaging have found a close correlation between high-risk coronary artery plaque and a common liver disease. The research revealed that... Read more

Nuclear medicine

view channel
Image: The RayPilot placed directly on the original carbon fiber couch (Photo courtesy of Micropos Medical).

Hypofractionated Prostate Radiotherapy Electromagnetic Positioning Tool Tracks Tumors in Real Time During Treatment

A new add-on tool to existing radiotherapy equipment has been designed to track a tumor at any time during the treatment. The system could enable the clinic to enhance precision in their cancer treatment,... Read more

General/Advanced Imaging

view channel

Photoacoustic Imaging Optimizes Visualization of Cancerous Tissues Using Time Reversal Technology

Unique time-reversal technology is being used to better focus light in tissue, such as muscles and organs. Current high-resolution optical imaging technology allows researchers to see about 1-mm-deep into the body. In an effort to enhance this imaging technology, the investigators are employing photoacoustic imaging, which... Read more

Imaging IT

view channel

Use of Radiology Data Mining Tool Reduces Length of Stay for CT Biopsy

Use of a data and analysis tool allows radiology clinical coordinators to facilitate a patient-centered imaging service, acting as a care manager for patients with positive findings on their computed tomography (CT) scans. Syed F. Zaidi, MD, president of Radiology Associates of Canton (RAC; OH, USA) and chief executive... Read more

Industry News

view channel
Image: Zygote’s human anatomy collections (Photo courtesy of Zygote).

Partnership to Provide 3-D Holographic Imaging to Medical Professionals

Zebra Imaging, Inc. (Austin, TX, USA), a provider of three-dimensional (3-D) holographic visualization technologies, reported on a partnership with the Zygote Media Group, Inc. (American Fork, UT, USA),... Read more
 

Events

01 Dec 2014 - 05 Dec 2014
11 Jan 2015 - 14 Jan 2015
Copyright © 2000-2014 Globetech Media. All rights reserved.